Unveiling the Diagnostic Value and Potential Therapeutic Targets of Phenylalanine Metabolism in Pancreatic Cancer via Integrated Multi‐Omics and Machine Learning
Xing Liu, Yibin Li, Fangfang Qin, Jianghong Ou · 2026
Read Unveiling the Diagnostic Value and Potential Therapeutic Targets of Phenylalanine Metabolism in Pancreatic Cancer via Integrated Multi‐Omics and Machine Learning by Xing Liu, Yibin Li, Fangfang Qin, Jianghong Ou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13570651.txt.
Description
Xing Liu, Yibin Li, Fangfang Qin, and Jianghong Ou search in 2026 for blood marks that can catch pancreatic cancer early. The cancer kills at a high rate, in part since it is found late. The team homes in on phenylalanine, a building block of proteins, and how the body handles it.
A gene-based test on 55 blood compounds tied phenylalanine to the cancer as a cause, not just a fellow rider. Eight genes linked to it split tumor from healthy tissue. The team tried 113 blends of 12 learning methods and kept the best test model. One gene, SLC6A14, stood out, and lab cell tests backed its pattern. Drug match sums found compounds that bind it with a firm hold. The work offers a test path and drug leads.
Catalog record
| CREATOR | Xing Liu, Yibin Li, Fangfang Qin, Jianghong Ou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |